Revolution Medicines, Inc. reports new financial obligation

Revolution Medicines, Inc. filed an 8-K covering a direct financial obligation and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.